Energetics in the pathogenesis of neurodegenerative diseases.
about
Zinc metallothionein imported into liver mitochondria modulates respirationNicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain.The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine depositsDifferential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residuesResveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.Microscopic basis for kinetic gating in Cytochrome c oxidase: insights from QM/MM analysis.Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons.Perceived effectiveness and barriers to physical therapy services for families and children with Friedreich ataxia.Insights into TOR function and rapamycin response: chemical genomic profiling by using a high-density cell array method.Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy.Rotenone Stereospecifically Increases (S)-2-Hydroxyglutarate in SH-SY5Y Neuronal CellsSeeking brain biomarkers for preventive therapy in Huntington disease.Fatty acids in energy metabolism of the central nervous systemAntigenically dominant proteins within the human liver mitochondrial proteome identified by monoclonal antibodies.Geldanamycin attenuates 3‑nitropropionic acid‑induced apoptosis and JNK activation through the expression of HSP 70 in striatal cells.Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.Oxidative stress, mitochondrial damage and neurodegenerative diseasesMitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death.Therapeutic approaches to delay the onset of Alzheimer's diseaseReactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging.Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology.Role of mitochondrial dysfunction in Alzheimer's disease.Post-traumatic inflammation following spinal cord injury.Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid.Mutations in cytochrome c oxidase subunit VIa cause neurodegeneration and motor dysfunction in DrosophilaThe use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.Neuropathology in Drosophila mutants with increased seizure susceptibility.Alteration of dopamine uptake into rat striatal vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its metabolites.The mitochondrial permeability transition in neurologic diseaseDifferent Forms of Selenoprotein M Differentially Affect Aβ Aggregation and ROS GenerationMitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease.MicroRNAs regulate the chaperone network in cerebral ischemia.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Lactate Shuttles in Neuroenergetics-Homeostasis, Allostasis and Beyond.
P2860
Q24617161-04FC2D1B-6F4A-459F-8763-42C5D1BC075BQ25255947-8202D1EB-C09F-491C-A476-317BF3104D28Q28200789-5D6B1E5B-AB90-4E78-A8B6-940750705894Q28211108-5383E73A-FAE5-40CD-9404-50564C9C2B3BQ28488046-24349A8D-8350-4E2D-A054-7E60D7CE4B7AQ30308666-10758C87-6F0D-44E9-B70E-11293B55AC72Q30394639-53A31262-296E-4854-864A-D606213809C3Q30477849-5E473D1E-0E32-4675-B84F-23F1653EC522Q30540990-9A2640CB-7786-41DA-A7B7-EE9668857A56Q30852003-FDF71CB4-891D-4AAF-B02C-87F3879B59B7Q31065368-FF70FC90-FA44-4636-994C-419286FA59EBQ33464532-7448D375-7C55-47E4-B4BE-18E7DD507537Q33606063-7AF47187-637F-4D0D-BE7E-695BF5EACA90Q33634475-9EDF7451-1914-4307-AE0B-D462BE297E4CQ33799386-3FD1E46C-4CB1-4E7C-813C-9E2FFA543B34Q33811254-99A98831-747B-43F6-B751-2523106F54E8Q33917550-F5E11444-4B52-4ED1-95B6-1C6C123439EDQ33943954-2A143053-3087-4B7E-AF65-2FDEFCB9E310Q34075502-87405F34-AD9C-4DD1-9584-62E6F7CF9EA5Q34094532-268B752C-8F59-4BEF-B0B4-C681D70BC140Q34094796-3C9A9B73-362B-4E79-97ED-19A0CD3B0150Q34172377-E61ACFB3-AC3D-4DFD-A43F-6EE6C596B2D0Q34243986-148AB596-2EBA-4CF7-AE7C-753DB305E0DBQ34379668-9529A445-2E87-4F90-9FA9-C69422DA92E8Q34784877-44E2335B-F0AA-4F80-9ED9-D7D1847C43BDQ34976262-217EDE9A-3FEC-416E-96B5-34D7FCBF1ADBQ35157997-0FD09104-DCD9-4B9D-9F57-7B8994456906Q35540810-57F0787D-CC6E-4439-91B1-91F078EB5AA4Q35846393-4385A488-5F68-4DAD-A148-D721C652352DQ36358871-1CD63C52-65A2-40A9-8BB3-0890BA631A8DQ36403694-150FC7BD-039E-4034-91C6-A885408A92F7Q36470506-8C797A09-D423-4010-B1F3-E5D8D26E5740Q36727046-088406A4-0DC5-4FE5-93F9-D506DB4F1A50Q36775895-9246D20C-9718-494B-9A05-F66498BCBCB0Q36790354-8932B9E7-4FC2-4056-838E-9A910D67B1F9Q37211755-21DCA26F-0D04-44AB-8E41-504206DA576CQ37239738-30423D32-8F46-4D12-A395-BF4B99B79F05Q37396241-0354C9A7-2962-4562-AD96-791817B34C3CQ37580731-88E7F514-FD75-413F-98A6-68A7C02AE6FEQ37620008-5DC734B6-491E-4B92-88D4-D4D0CF8A271A
P2860
Energetics in the pathogenesis of neurodegenerative diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Energetics in the pathogenesis of neurodegenerative diseases.
@ast
Energetics in the pathogenesis of neurodegenerative diseases.
@en
type
label
Energetics in the pathogenesis of neurodegenerative diseases.
@ast
Energetics in the pathogenesis of neurodegenerative diseases.
@en
prefLabel
Energetics in the pathogenesis of neurodegenerative diseases.
@ast
Energetics in the pathogenesis of neurodegenerative diseases.
@en
P1476
Energetics in the pathogenesis of neurodegenerative diseases.
@en
P2093
P304
P356
10.1016/S0166-2236(00)01584-8
P577
2000-07-01T00:00:00Z